8
Oct
2024

Kolon Biotech, Inc.

Exhibitor at CPHI Milan 2024 stand 4A49, API
About Us

KOLON Biotech is a trusted CDMO specialized in cell and gene therapy. Our team of experts, with extensive experience in producing cell and gene therapy as well as exosome therapy, oversees the entire manufacturing process. We are dedicated to operational excellence in GMP manufacturing and quality assurance, ensuring value delivery to our clients. KOLON Biotech's end-to-end CDMO service offer solutions aimed at shortening time-to-market, enhancing efficiency, and alleviating regulatory burdens.

  • KR
  • 2015
    On CPHI since
  • 50 - 99
    Employees
Company types
CMO/CDMO
Contact info
  • 54-1 Gieopdosi 1-ro, Daesowon-myeon, 27465, Chungju-si, Chungcheongbuk-do, Korea, Republic Of
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4A49, API

Products Featured at CPHI Milan 2024

  • 2D Automated Closed Platform

    Product 2D Automated Closed Platform

    Kolon Biotech’s 2D Automated Closed Platform can manufacture adherent cells in large scale with competitive costs and minimum contamination risk. With an automated system using a machine manipulator, we can set up the operation conditions and minimize human error ensuring batch-to-batch consistency. Th...
  • Tailored Services

    Product Tailored Services

    With extensive experience in various cell types including somatic cells, stem cells, immune cells, and iPSCs, we provide end-to-end services with cGMP regulation. For the product development, we can support the Cell Banking and pre-clinical batch production. In the early stages of clinical development, ...

Kolon Biotech, Inc. Resources (1)